Lineage Cell Therapeutics (LCTX) Tops Q2 EPS by 1c, beats revenue

Go back to Lineage Cell Therapeutics (LCTX) Tops Q2 EPS by 1c, beats revenue
(NYSE: LCTX) Delayed: 1.10 -0.01 (0.9%)
Previous Close $1.11    52 Week High
Open $1.11    52 Week Low
Day High $1.12    P/E N/A 
Day Low $1.09    EPS
Volume 917,015